Evidence map›Paper›PMID 12867506›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2003

Priming of excitatory synapses by alpha1 adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors.

Grant R J Gordon, Jaideep S Bains

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. αFrontiers in pharmacology · 2020
    Review
  4. Article
  5. Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. mGluR8 modulates excitatory transmission in the bed nucleus of the stria terminalis in a stress-dependent manner.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2011
    Article
  11. Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes.Journal of receptor and signal transduction research · 2011
    Review
  12. Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  13. Modulation of glutamatergic synaptic transmission in the bed nucleus of the stria terminalis.Progress in neuro-psychopharmacology & biological psychiatry · 2009
    Review
  14. Article
  15. Article
  16. Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  17. Article
  18. Article
  19. Can homeostatic circuits learn and remember?The Journal of physiology · 2006
    Review
  20. Noradrenaline triggers multivesicular release at glutamatergic synapses in the hypothalamus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Grant R J GordonNeuroscience Research Group, Department of Physiology and Biophysics, University of Calgary, Alberta, T2N 4N1, Canada.
Jaideep S Bains
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptive responses mediated by the hypothalamus require sustained activation until homeostasis is achieved. Increases in excitatory drive to the magnocellular neuroendocrine cells that mediate these responses, however, result in the activation of a presynaptic metabotropic glutamate receptor (mGluR) that curtails synaptic excitability. Recent evidence that group III mGluRs can be inhibited by protein kinase C prompted us to test the hypothesis that activation of PKC by noradrenaline (NA) inhibits group III mGluRs and increases excitatory synaptic input to these cells. To examine the effects of NA on miniature EPSCs (mEPSCs), we obtained whole-cell recordings from magnocellular vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus. All of the neurons tested in the current study displayed an alpha1 adrenoceptor-mediated increase in mEPSC frequency in response to NA (1-200 microm). The excitatory effects of NA were mimicked by the phorbol ester PMA and blocked by the PKC inhibitor calphostin C. The activation of PKC inhibits the efficacy of group III mGluRs, resulting in an increase in mEPSC frequency in response to a subsequent exposure to NA. By removing feedback inhibition, this mechanism effectively primes the synapses such that subsequent activation is more efficacious. The novel form of synaptic rescaling afforded by this cross-talk between distinct metabotropic receptors provides a means by which ascending catecholamine inputs can facilitate the control of homeostasis by hypothalamic networks.

Indexed as

AnimalsExcitatory Postsynaptic PotentialsFeedback, PhysiologicalGlutamic AcidGTP-Binding Protein alpha Subunits, Gq-G11Heterotrimeric GTP-Binding ProteinsHypothalamusIn Vitro TechniquesMaleNeuronsNorepinephrineParaventricular Hypothalamic NucleusPatch-Clamp TechniquesProtein Kinase CRatsRats, Sprague-DawleyGlutamic AcidGTP-Binding Protein alpha Subunits, Gq-G11Heterotrimeric GTP-Binding ProteinsNorepinephrineProtein Kinase CReceptors, Adrenergic, alpha-1Receptors, Metabotropic GlutamateTetradecanoylphorbol AcetateType C Phospholipases

Identifiers

PMID12867506
PMCPMC6740556
OpenAlexW1859305961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.